The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics

Dual antiplatelet therapy of aspirin and clopidogrel is pivotal for patients undergoing percutaneous coronary intervention. However, the variable platelets reactivity response to clopidogrel may lead to outcome failure and recurrence of cardiovascular events. Although many genetic and nongenetic fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Arwa M., Sheau Chin, Lim, Azri Mohamed Noor, Dzul, SK Abdul Kader, Muhamad Ali, Kah Hay, Yuen, Ibrahim, Baharudin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379098/
https://www.ncbi.nlm.nih.gov/pubmed/28421156
http://dx.doi.org/10.1155/2017/8062796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379098/
https://www.ncbi.nlm.nih.gov/pubmed/28421156
http://dx.doi.org/10.1155/2017/8062796

Ejemplares similares